Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis

NCT04205851 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Rheumatic Diseases

Interventions

DRUG: KIN-1901
DRUG: Placebo

Sponsor

Kinevant Sciences GmbH